Marshall Wace’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.04M Sell
170,756
-51,630
-23% -$2.1M 0.01% 1210
2025
Q4
$9.03M Buy
+222,386
New +$9.67M 0.01% 918
2025
Q2
Sell
-3,909
Closed -$236K 2766
2025
Q1
$236K Buy
+3,909
New +$252K ﹤0.01% 2354
2024
Q4
Sell
-7,401
Closed -$532K 2623
2024
Q3
$532K Sell
7,401
-68,014
-90% -$4.8M ﹤0.01% 1902
2024
Q2
$5.23M Buy
75,415
+22,326
+42% +$1.63M 0.01% 980
2024
Q1
$4.25M Buy
53,089
+16,876
+47% +$1.5M 0.01% 1062
2023
Q4
$3.97M Buy
36,213
+21,685
+149% +$2.24M 0.01% 991
2023
Q3
$1.47M Buy
+14,528
New +$1.67M ﹤0.01% 1363
2023
Q2
Sell
-6,156
Closed -$639K 2532
2023
Q1
$639K Buy
+6,156
New +$595K ﹤0.01% 2001
2020
Q3
Sell
-120,705
Closed -$8.69M 1617
2020
Q2
$8.69M Sell
120,705
-26,102
-18% -$1.82M 0.06% 322
2020
Q1
$8.41M Buy
+146,807
New +$13.5M 0.08% 249
2019
Q3
Sell
-159,433
Closed -$13.6M 1692
2019
Q2
$13.6M Sell
159,433
-239,289
-60% -$19.7M 0.11% 206
2019
Q1
$33.2M Buy
398,722
+238,500
+149% +$17.3M 0.31% 54
2018
Q4
$10.3M Buy
+160,222
New +$11M 0.11% 231
2015
Q4
Sell
-11,362
Closed -$542K 989
2015
Q3
$542K Buy
+11,362
New +$624K 0.01% 728
2014
Q3
Sell
-36,731
Closed -$1.62M 898
2014
Q2
$1.62M Buy
+36,731
New +$1.67M 0.02% 427

Other funds holding CNMD

Marshall Wace's CNMD Position: Q1 2026 in Review

Marshall Wace reduced its CONMED (CNMD) stake by 23% in Q1 2026, selling an estimated $2.1M and leaving 170,756 shares worth $6.04M. The position accounts for 0.01% of the portfolio, ranked #1210.

Marshall Wace first reported a position in CNMD in Q2 2014 and has held it in 16 quarters since. The position peaked at $33.2M in Q1 2019. 236 funds tracked by Wall St. Rank hold CNMD as of Q1 2026.

  • Marshall Wace held 170,756 shares of CONMED worth $6.04M as of Q1 2026.
  • Marshall Wace sold 51,630 CONMED shares in Q1 2026, an estimated $2.1M.
  • CONMED made up 0.01% of Marshall Wace's portfolio in Q1 2026, its #1210 holding.
  • Marshall Wace first reported a position in CONMED in Q2 2014 and has held it in 16 quarters since.
  • Marshall Wace's CONMED position peaked at $33.2M in Q1 2019.
  • 236 funds tracked by Wall St. Rank held CONMED as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.